<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dietary <z:hpo ids='HP_0001513'>obesity</z:hpo> is a major factor in the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and is associated with intra-adipose tissue <z:mp ids='MP_0005039'>hypoxia</z:mp> and activation of <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor 1α (HIF1α) </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report that, in mice, Hif1α activation in visceral white adipocytes is critical to maintain dietary <z:hpo ids='HP_0001513'>obesity</z:hpo> and associated pathologies, including <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This function of Hif1α is linked to its capacity to suppress β-oxidation, in part, through transcriptional repression of sirtuin 2 (Sirt2) <z:chebi fb="0" ids="15846">NAD(+)</z:chebi>-dependent deacetylase </plain></SENT>
<SENT sid="3" pm="."><plain>Reduced Sirt2 function directly translates into diminished deacetylation of PPARγ coactivator 1α (Pgc1α) and expression of β-oxidation and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> genes </plain></SENT>
<SENT sid="4" pm="."><plain>Importantly, visceral adipose tissue from human <z:mp ids='MP_0001261'>obese</z:mp> subjects is characterized by high levels of HIF1α and low levels of SIRT2 </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, by negatively regulating the Sirt2-Pgc1α regulatory axis, Hif1α negates adipocyte-intrinsic pathways of fatty acid catabolism, thereby creating a metabolic state supporting the development of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>